Dergiler / art / 2018 / Cilt: 33 - Sayı: 4

Clinical and Serologic Characteristics of Systemic Lupus Erythematosus in the Arab World: A Pooled Analysis of 3,273 Patients

Dergi
art
Sayfa
455–463
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Conclusion: SLE displays several different clinical and serologic characteristics, both among different Arab populations and in comparison to other ethnic groups.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objectives: This study aims to describe the clinical and immunological characteristics of systemic lupus erythematosus (SLE) in the Arab world.
📊
Temel Bulgular & Veri:Twenty-two articles from 11 countries including 3,273 patients (349 males, 2,924 females; mean age 28.9 years) met the inclusion criteria and were analyzed.
💡
Sonuç & Katkı:Conclusion: SLE displays several different clinical and serologic characteristics, both among different Arab populations and in comparison to other ethnic groups.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Özet

Objectives: This study aims to describe the clinical and immunological characteristics of systemic lupus erythematosus (SLE) in the Arab world. Materials and methods: We searched PubMed and Google Scholar for observational studies describing the clinical and serologic features of SLE in adult patients in the Arab world. We used the search terms “lupus in Arabs” and the names of individual Arab countries. Twenty-two articles from 11 countries including 3,273 patients (349 males, 2,924 females; mean age 28.9 years) met the inclusion criteria and were analyzed. Studies that reported on either clinical or serologic data in adult patients were included. Results: The mean age at disease onset was 28.9 years. The female to male ratio was 8.34:1. The most common clinical manifestations were arthralgia/arthritis (81.1%), anemia (55.6%), fatigue (53.4%), malar rash (53.1%) and renal manifestations (50.4%). Antinuclear antibodies were present in 97.2%, anti-double stranded deoxyribonucleic acid in 74.1%, anti-Ro/Sjögren syndrome A in 50.5%, anti-ribonucleoprotein in 43.5%, anti-Smith in 40.7% and anti-La/Sjögren syndrome B in 29.2%. The mortality rate was 7.6%. The frequency of various clinical and immunological manifestations varied between different regions. Conclusion: SLE displays several different clinical and serologic characteristics, both among different Arab populations and in comparison to other ethnic groups.

🔖

Bu Makaleye Atıf Yap

ADWAN, M. (2018). Clinical and Serologic Characteristics of Systemic Lupus Erythematosus in the Arab World: A Pooled Analysis of 3,273 Patients. art, Cilt: 33 - Sayı: 4, 455–463. https://ajindex.com/articles/152558

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (15)

  1. Mody GM, Parag KB, Nathoo BC, Pudifin DJ, Duursma J, Seedat YK. High mortality with systemic lupus erythematosus in hospitalized African blacks. Br J Rheumatol 1994;33:1151-3
  2. Arnett FC, Hamilton RG, Roebber MG, Harley JB, Reichlin M. Increased frequencies of Sm and nRNP autoantibodies in American blacks compared to whites with systemic lupus erythematosus. J Rheumatol 1988;15:1773-6
  3. Mok CC, Lau CS. Lupus in Hong Kong Chinese. Lupus 2003;12:717-22
  4. Boey ML, Peebles CL, Tsay G, Feng PH, Tan EM. Clinical and autoantibody correlations in Orientals with systemic lupus erythematosus. Ann Rheum Dis 1988;47:918-23
  5. Cervera R, Khamashta MA, Font J, Sebastiani GD, Gil A, Lavilla P, et al. Systemic lupus erythematosus: clinical and immunologic patterns of disease expression in a cohort of 1,000 patients. The European Working Party on Systemic Lupus Erythematosus. Medicine (Baltimore) 1993;72:113-24
  6. Pons-Estel BA, Catoggio LJ, Cardiel MH, Soriano ER, Gentiletti S, Villa AR, et al. The GLADEL multinational Latin American prospective inception cohort of 1,214 patients with systemic lupus erythematosus: ethnic and disease heterogeneity among “Hispanics”. Medicine (Baltimore) 2004;83:1-17
  7. Abutiban F, Mokkaddam K, Ameen E, Moussa M, Alsaeid K. Comparison between familial and sporadic systemic lupus erythematosus in Kuwaiti patients. Lupus 2009;18:86-91
  8. Al Arfaj AS, Khalil N. Clinical and immunological manifestations in 624 SLE patients in Saudi Arabia. Lupus 2009;18:465-73
  9. Alballa SR. Systemic lupus erythematosus in Saudi patients. Clin Rheumatol 1995;14:342-6
  10. Al-Heresh AM. Systemic Lupus Erythematosus among Jordanians: A Single Rheumatology Unit Experience. JRMS 2010;17:20-4
  11. Al-Jarallah K, Al-Awadi A, Siddiqui H, Al-Salim I, Shehab D, Umamaheswaran I, et al. Systemic lupus erythematosus in Kuwait--hospital based study. Lupus 1998;7:434-8
  12. Al-Maini MH, El-Ageb EM, Al-Wahaibi SS, Al-Farsi Y, Richens ER. Demographic, autoimmune, and clinical profiles of patients with systemic lupus erythematosus in Oman. Rheumatol Int 2003;23:186-91
  13. Al-Nasser A-AN, El-Shabrawy Aboul-Enein M, Al-Aska A-K. Systemic Lupus Erythematosus in Riyadh, Saudi Arabia. JRMS1988;108:90-3
  14. Al-Rayes H, Al-Swailem R, Arfin M, Sobki S, Rizvi S, Tariq M. Systemic lupus erythematosus and infections: a retrospective study in Saudis. Lupus 2007;16:755-63
  15. AlSaleh J, Jassim V, ElSayed M, Saleh N, Harb D. Clinical and immunological manifestations in 151 S